BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16700899)

  • 1. Review article: acid-related disease--what are the unmet clinical needs?
    Katz PO; Scheiman JM; Barkun AN
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():9-22. PubMed ID: 16700899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.
    Hunt RH
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():10-9. PubMed ID: 16303032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the opportunities and benefits of extended acid suppression.
    Scarpignato C; Pelosini I
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():23-34. PubMed ID: 16700900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative dosing for PPI therapy: rationale and options.
    Johnson DA
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S10-5. PubMed ID: 14671509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease.
    Katz PO
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():3-11. PubMed ID: 16483265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antacids in the management of disorders of the upper gastrointestinal tract. Review of clinical experience 1975-1985.
    Lanza FL; Sibley CM
    Am J Gastroenterol; 1987 Dec; 82(12):1223-41. PubMed ID: 3318401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
    Malfertheiner P; Fass R; Quigley EM; Modlin IM; Malagelada JR; Moss SF; Holtmann G; Goh KL; Katelaris P; Stanghellini V; Talley NJ; Tytgat GN; Wright NA
    Aliment Pharmacol Ther; 2006 Mar; 23(6):683-90. PubMed ID: 16556170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective.
    Freston JW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):51S-55S; discussion 55S-57S. PubMed ID: 9127627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.
    Triadafilopoulos G
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: gastric pH -- the most relevant predictor of benefit in reflux disease?
    Armstrong D
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():19-26; discussion 38-9. PubMed ID: 15456460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
    Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors in the management of GORD and PUD.
    Kenny E
    Ir Med J; 1993; 86(4):114. PubMed ID: 8395486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.